STRO SCHEDULE 13G: SEC filing
Coastlands Capital LP and affiliated entities
Filed with the SEC on · accession 0001104659-26-124373
STRO filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 9, 2026. Coastlands Capital LP and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 852,669 shares, or 5.14%, of Sutro Biopharma's common stock.
Summary of the filing
Coastlands Capital LP and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 852,669 shares, or 5.14%, of Sutro Biopharma's common stock. The filing is a passive investment disclosure, indicating no intent to influence control of the company.
Key details
✦ Ask GOAX AI about this filing — what it means for STRO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for STRO?
Click hereFrequently asked questions
What did STRO file with the SEC on Nov 9, 2026?
STRO filed a SCHEDULE 13G (SEC filing). Coastlands Capital LP and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 852,669 shares, or 5.14%, of Sutro Biopharma's common stock. The filing is a passive investment disclosure, indicating no intent to influence control of the company.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
Other STRO SEC filings
Get alerts when STRO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days